Company: FCRX
Filing Date: 2025-06-06
Form Type: N-2/A
Source: 0001193125-25-137120
Chunk: 17

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-06-06
Form: N-2/A
Chunk 17
---
| Income based fees and capital gains incentive fees                                            |     |  1.96 |  -7 |
| Interest payments on borrowed funds                                                           |     |  8.16 |  -8 |
| Other expenses                                                                                |     |  1.32 |  -9 |
| Acquired fund fees and expenses                                                               |     |  1.95 | -10 |
| Total annual expenses                                                                         |     | 16.20 | -11 |

| (1) | In the event that the securities to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load (underwriting discount or commission). Purchases of shares of our common stock on the secondary market are not subject to sales charges but may be subject to brokerage commissions or other charges. The table does not include any sales load that stockholders may have paid in connection with their purchase of shares of our common stock. |

| (2) | The related prospectus supplement will disclose the estimated amount of offering expenses, the offering price and the offering expenses borne by us as a percentage of the offering price. |

| (3) | The expenses of the dividend reinvestment plan are included in “Other expenses.” The plan administrator’s fees under the plan are paid by us. If a participant elects by notice to the plan administrator in advance of termination to have the plan administrator sell part or all of the shares held by the plan administrator in the participant’s account and remit the proceeds to the participant, the plan administrator is authorized to deduct a transaction fee of up to $15 plus a $0.10 per share fee from the proceeds. See “Dividend Reinvestment Plan” below for more information. |

| (4) | The related prospectus supplement will disclose the offering price and the total stockholder transaction expenses as a percentage of the offering price. |

| (5) | The “consolidated net assets attributable to common stock” used to calculate the percentages in this table is our net assets as of March 31, 2025. |

| (6) | The base management fee referenced in the table above reflects the actual base management fees incurred during the three months ended March 31, 2025. The base management fee under the Amended and Restated Investment Advisory Agreement, dated as of January 5, 2021, by and between us and the Advisor (the “Investment Advisory Agreement”) is calculated and payable quarterly in arrears at an annual